CC
BEAM icon

Corton Capital’s Beam Therapeutics BEAM Stock Holding History

Corton Capital’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,917
Closed -$243K – 409
2024
Q3 		$243K Sell
9,917
-12,047
-55% -$311K 0.12% 279
2024
Q2 		$515K Buy
+21,964
New +$539K 0.27% 44
2024
Q1 		– Sell
-11,903
Closed -$324K – 513
2023
Q4 		$324K Sell
11,903
-8,602
-42% -$214K 0.1% 293
2023
Q3 		$493K Buy
20,505
+9,818
+92% +$263K 0.25% 100
2023
Q2 		$341K Buy
+10,687
New +$347K 0.16% 182

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Corton Capital's BEAM Position: Q4 2024 in Review

Corton Capital sold out of Beam Therapeutics (BEAM) in Q4 2024, closing a stake of 9,917 shares — an estimated $243K sold.

Corton Capital first reported a position in BEAM in Q2 2023 and held it in 5 quarters. The position peaked at $515K in Q2 2024. 231 funds tracked by Wall St. Rank hold BEAM as of Q4 2024.

  • Corton Capital reported no remaining Beam Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 9,917 Beam Therapeutics shares in Q4 2024, an estimated $243K.
  • Corton Capital first reported a position in Beam Therapeutics in Q2 2023 and held it in 5 quarters.
  • Corton Capital's Beam Therapeutics position peaked at $515K in Q2 2024.
  • 231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.